lecture 1 Flashcards

1
Q

Intracellular Receptors

A
  • Bind ligands that are very LIPOPHILIC
  • Liigand diffuses through cell membranes to interact with its receptor
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Receptors with Intrinsic enzymatic activity

A
  • Single membrane spanning domain
  • Ligand binds to extracellular domain that turns on switch inside the cell

–> commonly activates protein and lipid kinase cascades that leads to protein phosphatases

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

receptors that directly associate with intracellular enzymes

A

transmembrane receptor associated with enzyme

  • receptor can associate with kianses or proteases
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Ligand-gated ion channel

A
  • binding of a ligand to the channel opens up the pore
  • allows ions to move down concentration gradient
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

7-membrane spanning receptor

A
  • G-protein
  • coupling to G-protein liberates one of the subunit that turns on downstream signaling events
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

describe the variation of receptor availability

A
  • Receptor availability is dynamic
  • Continued STIMULATION/ACTIVATION of receptor leads to DOWNREGULATION (DECREASE drug-induced response)
  • Continued exposure of a recetpor to INHIBITOR may cause UPREGULATION (Observation of phsyiological response despite presence of inhibitor)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

define Potency

A
  • Measurement of drug dose used to compare the relative affinity and effectiveness of two or more drugs
  • most conveniently done by comparing the EC50 of two or more agents

(EC50 = concentration of drug that produces a half maximal effect)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

define eficacy

A
  • the maximal effect a drug can induce (Emax)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

define Bmax and Kd

A
  • Bmax = maximum binding/all receptors are full
  • Kd = ligand concentration at a point where 1/2 your receptors are free (represents the affinity of a ligand for tis receptors)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

define pharmacy

A

science and profession concerned with the preparation, storage, dispensing and proper utilization of drug products

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

define pharmacology

A

pharmacology is the biomedical science concerned with the interaction of chemical substances with living cells, tissues and organisms. It is particularly concerned with the mechanisms by which drugs counteract the manifestations of disease

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

define toxicology

A

Toxicology is the science of poisons and toxicity. It focuses on the harmful effects of drugs and other chemicals and on the mechanisms by which toxic agents produce pathological changes, disease and death.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

define pharmacokinetics

A

divison of pharmacology focused on processes that affect drug concentration in the body. These processes include absorption, distribution, metabolism and elimination. Kinetic parameters will AFFECT the DRUF BIOAVAILABILITY

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

define pharmacodynamics

A

division of pharmacology focused on how a drug produces an effect. Area of interest when studying pharmacodynamics would include drug targets or receptors, signal transduction pathways regulated by drugs and the physiological and therapeutic effects caused by particular agent

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

describe phase 1

A
  • Limits of safe dosing range
  • small number of subjects
  • Is it safe?
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

phase 2

A
  • Does it work?
  • relatively small number of subjects (more than phase 1)
17
Q

phase 3

A
  • well controlled, more patients (randomized double-blind study)
  • larger number of people
18
Q

phase 4

A
  • monitor during clinical use
  • postmarketing surveillance
19
Q

animal testin

A
  • experimentation
  • drug characterization (molecular, cellular etc)
  • TOXICITY (MINIMAL LETHAL DOSE)